On 25 November, five pioneering life science start-ups pitched to a panel of investors as they completed the final part of their journey on the East Midlands AHSN Accelerator, delivered by BioCity. The panel were blown away by the pitches from the entrepreneurs, with wide-ranging innovations...
A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment. BioCity Accelerator alumni, In4Derm Ltd, is an innovative drug discovery company developing the next generation of topical and oral therapies for widespread...
On 27 November, eight innovative start-ups from the Oxford AHSN Accelerator, delivered by BioCity presented their progress and their pitches for future investment to a panel of experts from Oxford AHSN, BioCity and industry. Their pitches were the culmination of the second Oxford AHSN Accelerator programme, delivered by...
BioCity Accelerator alumni, Convert Technologies, have been awarded funding by InnovateUK for a £500k project to build an asset tracking solution. The funding will enable the 12-18 months development project, called Range-IT, to start on 1st November 2020. Convert have received strategic support from Althea...
MediCity Glasgow, a medical science business with the aim of generating £5 million has raised £26m and seen the creation of 201 new jobs. Since it was set up five years ago, MediCity Glasgow has helped create 70 new life science and med-tech companies The company supports...
University of Dundee researchers hope to turn their spinout venture into a biotech company worth hundreds of millions of pounds by helping to treat people with eczema, rheumatoid arthritis and other inflammatory conditions. In4Derm Ltd is an innovative drug discovery company developing the next generation of...
Opportunity North East (ONE) is launching a new programme to help translate life sciences research and ideas into growth businesses that positively impact healthcare delivery and patient outcomes. The programme of four 90-minute online workshops will help researchers, clinicians and potential entrepreneurs to start their commercialisation journeys. ONE...
BioCity 2019 Accelerator programme graduate company, Myndr, has secured six-figure funding from the government’s business innovation programme. Myndr, which is based in Newcastle, has received £300k investment from Innovate UK to expand its proposition. Founded by Lizzy Hodcroft and Emma Reilly, Myndr aims to create an anonymous platform,...
Friday 06 December, Nottingham, England UK. At a black-tie event held in Nottingham last night, 200 leading names and rising stars of the life sciences came together at the Medilink East Midlands Business Awards 2019. A celebration of innovation within the region, a total of seven...
Coronary heart disease is one of the leading causes of death within the UK. Every day over 2500 patients present at A&E departments across the UK with chest pain, indicative of a suspected heart attack. Of these, only 20% will have a confirmed heart attack....